954228-21-8 Usage
Description
[1-(2-chloropyrimidin-4-yl)piperidin-4-yl]methanol is a chemical compound featuring a piperidine ring and a chloropyrimidine ring, along with a methanol group. This versatile molecule holds potential for applications in various fields, including pharmaceuticals, agrochemicals, and material science.
Uses
Used in Pharmaceutical Industry:
[1-(2-chloropyrimidin-4-yl)piperidin-4-yl]methanol is used as a synthetic target for the development of new drugs, leveraging its unique structure and reactivity. The chloropyrimidine group may offer specific chemical properties, while the piperidine ring could influence the compound's pharmacological effects, making it a promising candidate for therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, [1-(2-chloropyrimidin-4-yl)piperidin-4-yl]methanol is used as a building block for the creation of novel agrochemicals. Its chemical structure may contribute to the development of more effective and targeted pesticides or other agricultural products.
Used in Material Science:
[1-(2-chloropyrimidin-4-yl)piperidin-4-yl]methanol is utilized as a component in the synthesis of advanced materials, taking advantage of its potential for chemical modifications and derivatization. The presence of the methanol group may facilitate the development of new materials with enhanced properties for various applications in material science.
Check Digit Verification of cas no
The CAS Registry Mumber 954228-21-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,4,2,2 and 8 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 954228-21:
(8*9)+(7*5)+(6*4)+(5*2)+(4*2)+(3*8)+(2*2)+(1*1)=178
178 % 10 = 8
So 954228-21-8 is a valid CAS Registry Number.
954228-21-8Relevant articles and documents
PROSTACYCLIN RECEPTOR AGONIST
-
Paragraph 0160-0162; 0166-0168, (2020/12/22)
A compound represented by formula (I) or an isomer or a pharmaceutically acceptable salt thereof. The present invention also relates to an application of the same in preparing a drug for treating a disease related to a PGI2 receptor.
